Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2015

Open Access 01-12-2015 | Poster presentation

Use of sulphur hexafluoride microbubbles injection to identify the sentinel lymph node in breast cancer patients: initial experience in a UK breast unit

Authors: Alice Leaver, Simon Lowes, Peter Newton, Linsley Lunt, Anuradha Anand, Linda Hutchinson, Sally Athey, Amanda Jane Potterton, Sheetal Sharma, Alan Redman

Published in: Breast Cancer Research | Special Issue 1/2015

Login to get access

Excerpt

In our Trust, all breast cancer patients undergo preoperative axillary staging with ultrasound. Over the past year we have introduced intradermal sulphur hexafluoride microbubbles ultrasound contrast injection to help identify sentinel lymph nodes for a preoperative needle biopsy in each patient. Only patients with malignant node morphology on grey-scale ultrasound undergo biopsy without microbubbles injection. …
Metadata
Title
Use of sulphur hexafluoride microbubbles injection to identify the sentinel lymph node in breast cancer patients: initial experience in a UK breast unit
Authors
Alice Leaver
Simon Lowes
Peter Newton
Linsley Lunt
Anuradha Anand
Linda Hutchinson
Sally Athey
Amanda Jane Potterton
Sheetal Sharma
Alan Redman
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2015
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3766

Other articles of this Special Issue 1/2015

Breast Cancer Research 1/2015 Go to the issue

Poster presentation

Contrast-enhanced spectral mammography: what is the 'added value' in a symptomatic setting? Initial findings from a UK centre

Poster presentation

The 3.5-year to 13.5-year follow up of 137 lesions of uncertain malignant potential (B3 lesions) diagnosed by vacuum-assisted biopsy alone

Poster presentation

Initial outcome of contrast-enhanced spectral mammography in lesion characterisation in the mammographically dense breast

Poster presentation

A review of BRCA gene carrier demographics in Wales

Poster presentation

Impact of index of multiple deprivation and ethnicity on breast screening uptake in the North West of England

Oral presentation

Breast density measurements with ultrasound tomography: a comparison with non-contrast MRI
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits